Archives
Simply Stated: Research Updates in Congenital Muscular Dystrophy (CMD)
Congenital muscular dystrophy (CMD) refers to a group of genetic muscle diseases that become apparent within the first two years after birth. CMDs belong to the larger group of disorders…
Tags: Simply Stated
MDA Advocates Returned to Capitol Hill (Virtually)
After a three-year hiatus, advocates went back to Capitol Hill, but this time virtually. On September 28th and 29th, families from across the country raised their voices and urged lawmakers…
Clinical Trial Alert: Phase 3 Study of Inebilizumab in Adults with Myasthenia Gravis
Researchers at Horizon Therapeutics are seeking adults living with myasthenia gravis (MG) to participate in a phase 3 clinical trial to evaluate the safety and efficacy inebilizumab to treat MG. Inebilizumab…
Tags: Clinical Trial Alert
Accessibility and Workplace Rights & Resources
For those living with a disability who are looking to join or remain in the workforce, the MDA Resource Center offers valuable tips for finding a job that plays to…
Tags: Employment, Resources
The Return of the Best Week of Summer
Looking Back to Move Ahead There is no better way to acknowledge The Year of Independence than taking a look back at our first in-person MDA Summer Camp sessions in…
Tags: Summer Camp
Year of Independence
Acosta CEO Brian Wynne talks with MDA about empowering employees with disabilities and raising money for MDA.
Tags: Employment
Tips for Better Hygiene With a Disability — And Why It Matters
Having good hygiene with a disability, especially with a neuromuscular disease, can be challenging. Here are some suggestions from experts to make daily cleansing activities easier.
Tags: Caregiving, Featured Content, Resources
Easy Clean: Bathing Products for People with Disabilities
If you have a neuromuscular disease, is there anything more energy-draining than taking a shower or bath? It’s important, though, and not just because you don’t want to stink up the…
MDA Celebrates the Approval of Relyvrio from Amylyx for the Treatment of ALS
On Sept 29, the US Food and Drug Administration (FDA) granted approval of sodium phenylbutyrate/taurursodiol (Relyvrio) for the treatment of people with amyotrophic lateral sclerosis (ALS). To date, Relyvrio is…
Tags: Drug Approval, Research Advances
How the ADA’s Employment Rights Apply to Job Seekers
Learn how the ADA protects rights for job applicants during the interviewing and hiring processes.
Tags: Employment